Coronaviruses
Title:Vitamin D3 Deficiency and COVID-19
Volume: 2 Issue: 1
Author(s): Olen R. Brown*Martin R. Hullender
Affiliation:
- Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK,United States
Export Options
About this article
Cite this article as:
Brown R. Olen *, Hullender R. Martin , Vitamin D3 Deficiency and COVID-19, Coronaviruses 2021; 2(1) . https://dx.doi.org/10.2174/2666796701999200914112352
DOI https://dx.doi.org/10.2174/2666796701999200914112352 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
Article Metrics

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Stress and Physical Inactivity: Two Explosive Ingredients for the Heart in
COVID-19 Pandemic Times
Current Cardiology Reviews Mechanism of Cardiac Pathogenesis and Cardiotoxicity of Anti- COVID-19 Drugs
Coronaviruses Protein Structure Prediction in Structure Based Drug Design
Current Medicinal Chemistry A Perspective of Viruses and the Outbreak of a Novel Coronavirus SARS-CoV- 2
Current Enzyme Inhibition Artificial Intelligence in Pharmaceutical Field - A Critical Review
Current Drug Delivery Potential Pathway that Could Treat Coronaviruses (COVID-19)
Current Biochemical Engineering (Discontinued) Natural Compounds as Heme Oxygenase-1 Inducers to Reduce the Deleterious Consequences Following SARS-CoV-2 Infection
Current Chemical Biology COVID-19: Innovative Antiviral Drugs Required for Long-Term Prevention and Control of Coronavirus Diseases
Current Medicinal Chemistry <i>Chemi-Informatic</i> Approach to Investigate Putative Pharmacoactive Agents of Plant Origin to Eradicate COVID-19
Coronaviruses Peptide-Based Inhibitors of the HIV Envelope Protein and Other Class I Viral Fusion Proteins
Current Pharmaceutical Design COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy
Current Pharmaceutical Design Current Advances in Novel SARS-CoV-2 Disease (COVID-19) Treatment and Intervention Strategies
Coronaviruses Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak
Mini-Reviews in Medicinal Chemistry Synthesis of Four Heterocyclic Drug Molecules Repurposed for COVID-19
Mini-Reviews in Organic Chemistry An Augmented Passive Immune Therapy to Treat Fulminant Bacterial Infections
Recent Patents on Anti-Infective Drug Discovery Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design COVID-19 Improved Diagnoses Based on the Open-morphology Filter and Deep-learning
Recent Patents on Engineering miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis
Current Pharmaceutical Design Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic
Coronaviruses Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Current Pharmaceutical Design